Rule Change on Generic Drug Labeling Could Cost Billions

By Freddie Allen NNPA Washington Correspondent   WASHINGTON (NNPA) – A proposed rule change for generic drug labels, crafted by the Food and Drug Administration, could cost patients, health care providers and drug manufacturers billions of dollars and limit access to affordable, prescription drugs for Read More